Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

34.64

+1.20 (3.59%)

At close: Jul 2, 2026, 4:00 PM EDT

34.55

-0.09 (-0.26%)

After-hours: Jul 2, 2026, 7:59 PM EDT

Teva Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,741	3,556	3,300	3,226	2,801	2,165
Cash & Short-Term Investments	3,741	3,556	3,300	3,226	2,801	2,165
Cash Growth	120.45%	7.76%	2.29%	15.17%	29.38%	-0.55%
Accounts Receivable	3,393	3,709	3,059	3,408	3,696	4,529
Inventory	3,176	3,179	3,007	4,021	3,833	3,818
Other Current Assets	3,399	3,503	3,186	1,829	1,721	2,059
Total Current Assets	13,710	13,946	12,552	12,485	12,051	12,573
Net Property, Plant & Equipment	4,333	4,425	4,948	6,147	6,158	6,477
Other Intangible Assets	3,609	3,781	4,418	5,387	6,270	7,466
Goodwill	15,822	16,000	15,147	17,177	17,633	20,040
Other Long-Term Assets	2,567	2,596	2,261	2,282	1,899	1,111
Total Assets	40,040	40,748	39,326	43,479	44,011	47,666
Accounts Payable	2,596	2,531	2,203	2,602	1,887	1,686
Accrued Expenses	6,878	7,569	7,094	6,917	6,467	7,012
Short-Term Debt	2,612	1,820	1,781	1,672	2,109	1,426
Other Current Liabilities	1,445	1,536	1,718	1,057	1,005	903
Total Current Liabilities	13,532	13,456	12,796	12,247	11,469	11,027
Long-Term Debt	14,015	14,986	16,002	18,161	19,103	21,617
Long-Term Leases	280	288	296	320	349	416
Other Long-Term Liabilities	3,982	4,104	4,511	4,625	4,493	3,362
Total Long-Term Liabilities	18,277	19,379	20,809	23,106	23,944	25,395
Total Liabilities	31,809	32,834	33,605	35,353	35,413	36,422
Common Stock	59	58	-	57	57	57
Treasury Stock	-4,128	-4,128	-	-4,128	-4,128	-4,128
Additional Paid-in Capital	28,203	28,133	-	27,807	27,688	27,561
Accumulated Other Comprehensive Income	-2,512	-2,391	-	-2,697	-2,838	-2,683
Retained Earnings	-13,394	-13,762	-	-13,534	-12,975	-10,529
Total Common Shareholders' Equity	8,228	7,910	5,373	7,506	7,804	10,278
Minority Interest	4	4	347	620	794	966
Shareholders' Equity	8,232	7,914	5,720	8,126	8,598	11,244
Total Liabilities & Equity	40,040	40,748	39,326	43,479	44,011	47,666
Total Debt	16,907	17,094	18,079	20,153	21,561	23,459
Net Cash (Debt)	-13,166	-13,538	-14,779	-16,927	-18,760	-21,294
Net Cash Per Share	-11.26	-11.64	-13.07	-15.13	-16.90	-19.24
Book Value	8,228	7,910	5,373	7,506	7,804	10,278
Book Value Per Share	7.04	6.80	4.75	6.71	7.03	9.28
Tangible Book Value	-11,203	-11,871	-14,192	-15,058	-16,099	-17,228
Tangible Book Value Per Share	-9.58	-10.21	-12.55	-13.46	-14.50	-15.56

SEC Filings: 10-K · 10-Q